Developing Innovative Biologics

We combine indigenous entrepreneurial spirit with world class expertise and experience to develop an industry leading pipeline of immuno-oncology targets. We have developed Antibody engineering platforms that are used to develop therapeutic monoclonal antibody products against innate immunity targets.



A combined experience exceeding 100 years.
Expertise in antibody engineering and process development.


Well-equipped 14,785 sqft Lab for complete process development.
ISO 9001:2015 Certified

Intellectual Property

A number of provisional patents focusing on novel biomolecules and biosimilars filed.